KPMG reviews the effects of the transition that began on 1 January 2015 to a new method of remuneration. The introduction of the dispensing fee has changed the business model for the pharmacy, significantly reducing the link between sales and margin. Part of the remuneration officinale is now disconnected from the price of reimbursable drugs.
After two years of decline, sales timidly increases of 0.1% on average. Sales of reimbursable products fell by 0.6% (against 2% last year) while revenues increased beyond 2%. KPMG hypothesized that without the new remuneration, the decline would have been greater.